Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID‐19 patients

Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID‐19 patients

Abstract We propose a new hypothesis that the established drug pentoxifylline deserves attention as a potential repurposed therapeutic for COVID‐19. Pentoxifylline is an immunomodulator with anti‐inflammatory properties. It is a nonselective phosphodiesterase inhibitor and through Adenosine A2A Rece...

Full description

Bibliographic Details
Main Authors: Bruce M. Hendry, Nina Stafford, Ahran D. Arnold, Arvind Sangwaiya, Vijay Manglam, Stuart D. Rosen, Jayantha Arnold
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Pharmacology Research & Perspectives
Subjects:
COVID‐19
cytokine
immunomodulation
pentoxifylline
pneumonia
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/prp2.631

Internet

https://doi.org/10.1002/prp2.631

Similar Items